Epigenomics' Pending Acquisition

Epigenomics raised a round of funding on April 28, 2017. Investors include Cathay Fortune International.

Epigenomics is a molecular diagnostics company focusing on blood-based detection of cancers using its proprietary DNA methylation technology. The company develops and commercializes blood-based diagno…

Articles about Epigenomics' Pending Acquisition: